Yeast, Human Stem Cells Drive Discovery of New Parkinson’s Disease Drug Targets

News   Oct 30, 2013

 
Yeast, Human Stem Cells Drive Discovery of New Parkinson’s Disease Drug Targets
 
 
 

RELATED ARTICLES

Brian Berridge Set to Manage National Toxicology Program

News

The National Toxicology Program (NTP) has named Brian Berridge, D.V.M., Ph.D., as its new Associate Director. Berridge, formerly of GlaxoSmithKline, will oversee day-to-day operations as NTP coordinates toxicology research and testing across nine different federal agencies.

READ MORE

Heart-muscle Patches Created from Human Cells Improve Recovery from Heart Attacks

News

Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.

READ MORE

Sensory Interneurons Created from Stem Cells

News

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have, for the first time, coaxed human stem cells to become sensory interneurons — the cells that give us our sense of touch.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE